Pharmacogenomics Flashcards
Pharmacogenomics definition
variations in several genes (genome) that influence a drug’s response
Warfarin metabolism (slide 15 no.1)
..
NHS approach
NHS White/Board paper
which genotypes are involved in alterations to warfarin metabolism?
CYP2C9, VKORC1
Codeine metabolism
Codeine to morphine by CYP2D6
to norcodeine by 3A4
What are recommendations for:
- normal (extensive) metabolisers of codeine?
- poor metabolisers
- intermediate metabolisers
- ultrarapid (increased formation of morphine)
- use label recommendations
- avoid codeine (lack of efficacy)
- Use label, adjust if no response
- avoid codeine due to potential for toxicity
MHRA guidance for ultrarapid metabolisers?
codeine is contraindicated
Clopidogrel metabolism
CYP2C19
poor clopidogrel metaboliser risks
2-fold increase atherosclerosis
4-fold risk of stent thrombosis
20-40% of patients non or poor responders to clopidogrel
Allele meaning for tamoxifen and dose recommendations
- 2 inactive = poor metaboliser. Increase breast cancer risk
- 1 active/inactive or variation = intermediate. Increased risk
- 2 active = UM = no recommendation
% patients with poor tamoxifen response
20-30% GENOTYPE STATUS NOT CONSIDERED IN DECISION MAKING
how much could warfarin pharmacogenomic testing save in US?
1.1 billion dollars
CYP variability
gene deletion - no enzyme - no metabolism
gene duplication - higher enzyme levels - increased metabolism of parent drug
HLA-B*1502
Carbamazepine increased risk of SJS and TENS (Toxic Epidermal Necrolysis)
HLA-B*5701
Abacavir sensitivity